103 related articles for article (PubMed ID: 11574136)
1. Serum erythropoietin levels in ovarian cancer patients receiving chemotherapy.
Pedain C; Herrero J; Künzel W
Eur J Obstet Gynecol Reprod Biol; 2001 Oct; 98(2):224-30. PubMed ID: 11574136
[TBL] [Abstract][Full Text] [Related]
2. Serum erythropoietin levels in gynecologic cancer patients during cisplatin combination chemotherapy.
Hasegawa I; Tanaka K
Gynecol Oncol; 1992 Jul; 46(1):65-8. PubMed ID: 1634143
[TBL] [Abstract][Full Text] [Related]
3. Plasma erythropoietin concentrations in patients receiving intensive platinum or nonplatinum chemotherapy.
Canaparo R; Casale F; Muntoni E; Zara GP; Della Pepa C; Berno E; Pons N; Fornari G; Eandi M
Br J Clin Pharmacol; 2000 Aug; 50(2):146-53. PubMed ID: 10930966
[TBL] [Abstract][Full Text] [Related]
4. Effect of recombinant human erythropoietin on anticancer drug-induced anaemia.
Matsumoto T; Endoh K; Kamisango K; Akamatsu K; Koizumi K; Higuchi M; Imai N; Mitsui H; Kawaguchi T
Br J Haematol; 1990 Aug; 75(4):463-8. PubMed ID: 2206997
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin response is inadequate in cancer patients receiving chemotherapy.
Lee SJ; Kwon JH; Jung CW
Int J Hematol; 2001 Dec; 74(4):416-20. PubMed ID: 11794697
[TBL] [Abstract][Full Text] [Related]
6. The effect of subcutaneous recombinant human erythropoietin (r-HuEPO) on anemia in cancer patients receiving platinum-based chemotherapy.
Malik IA; Khan ZK; Hakimali A; Sabih M; Rehman G
J Pak Med Assoc; 1998 May; 48(5):127-31. PubMed ID: 9813972
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the serum erythropoietin levels in chemotherapy-naive and cisplatin-treated cancer patients.
Arslan M; Evrensel T; Kurt E; Demiray M; Ercan I; Kanat O; Ozkan A; Manavoglu O
Neoplasma; 2005; 52(1):43-5. PubMed ID: 15739025
[TBL] [Abstract][Full Text] [Related]
8. An analysis of potential factors allowing an individual prediction of cisplatin-induced anaemia.
Pivot X; Guardiola E; Etienne M; Thyss A; Foa C; Otto J; Schneider M; Magné N; Bensadoun RJ; Renée N; Milano G
Eur J Cancer; 2000 May; 36(7):852-7. PubMed ID: 10785589
[TBL] [Abstract][Full Text] [Related]
9. [Serum erythropoietin concentration in women with uterine or ovarian tumors].
Chudek J; Wiecek A; Kokot F; Grochal A; Switała J; Kanwiszer J
Przegl Lek; 1998; 55(2):47-50. PubMed ID: 9695642
[TBL] [Abstract][Full Text] [Related]
10. Recombinant human erythropoietin in the treatment of cancer-related or chemotherapy-induced anaemia in patients with solid tumours.
Nowrousian MR
Med Oncol; 1998 Aug; 15 Suppl 1():S19-28. PubMed ID: 9785333
[TBL] [Abstract][Full Text] [Related]
11. Use of darbepoetin alfa in European clinical practice for the management of chemotherapy-induced anaemia in four tumour types: final data from the CHOICE study.
Aerts JG; Swieboda-Sadlej A; Karanikiotis C; Labourey JL; Galid A; Wheeler T; Pujol B; Van Belle S
Curr Med Res Opin; 2012 Jul; 28(7):1089-99. PubMed ID: 22642866
[TBL] [Abstract][Full Text] [Related]
12. Response predicting factors to recombinant human erythropoietin in cancer patients undergoing platinum-based chemotherapy.
González-Barón M; Ordóñez A; Franquesa R; Constenla M; Montalar J; Gili F; Camps C; Sancho JF; Pérez-Cachot P
Cancer; 2002 Dec; 95(11):2408-13. PubMed ID: 12436449
[TBL] [Abstract][Full Text] [Related]
13. Epoetin alfa in platinum-treated ovarian cancer patients: results of a multinational, multicentre, randomised trial.
Wilkinson PM; Antonopoulos M; Lahousen M; Lind M; Kosmidis P;
Br J Cancer; 2006 Apr; 94(7):947-54. PubMed ID: 16570051
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human erythropoietin treatment for chemotherapy-related anemia in children.
Varan A; Büyükpamukçu M; Kutluk T; Akyüz C
Pediatrics; 1999 Feb; 103(2):E16. PubMed ID: 9925862
[TBL] [Abstract][Full Text] [Related]
15. Serum erythropoietin in rheumatoid arthritis and other inflammatory arthritides: relationship to anaemia and the effect of anti-inflammatory treatment.
Birgegård G; Hällgren R; Caro J
Br J Haematol; 1987 Apr; 65(4):479-83. PubMed ID: 3580305
[TBL] [Abstract][Full Text] [Related]
16. Low 1,25-dihydroxyvitamin D level is associated with erythropoietin deficiency and endogenous erythropoietin resistance in patients with chronic kidney disease.
Kim IY; Kim JH; Kim MJ; Lee DW; Hwang CG; Han M; Rhee H; Song SH; Seong EY; Lee SB
Int Urol Nephrol; 2018 Dec; 50(12):2255-2260. PubMed ID: 30136086
[TBL] [Abstract][Full Text] [Related]
17. [Erythropoietin and cisplatin-induced neuropathies in cancer patients].
Mangiameli A; Spina S; Iannetti E; Catalano D; Spadaro D; Trovato GM
Clin Ter; 2002; 153(3):177-80. PubMed ID: 12161978
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin reduces anemia and transfusions: A randomized trial with or without erythropoietin during chemotherapy.
Dunphy FR; Harrison BR; Dunleavy TL; Rodriguez JJ; Hilton JG; Boyd JH
Cancer; 1999 Oct; 86(7):1362-7. PubMed ID: 10506726
[TBL] [Abstract][Full Text] [Related]
19. Serum erythropoietin levels in the elderly.
Kario K; Matsuo T; Nakao K
Gerontology; 1991; 37(6):345-8. PubMed ID: 1765284
[TBL] [Abstract][Full Text] [Related]
20. Identification of risk factors for requiring transfusion during front-line chemotherapy for ovarian cancer.
Hensley ML; Lebeau D; Leon LF; Venkatraman E; Waltzman R; Sabbatini P; Almadrones L; Chi D; Spriggs D
Gynecol Oncol; 2001 Jun; 81(3):485-9. PubMed ID: 11371143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
